Cover Image

From atherosclerosis to cabg

Mohammad Ali Sheikhi, Ahmad Ebadi*, Asghar Ramezani, Behnam Gholizadeh

Abstract


Ischemic heart disease (IHD) is diagnosed in approximately 30-34% patients who undergo surgery. In other words, 1 out of 3 patients scheduled for surgery is an IHD patient. Cardiovascular diseases are in fact the main health problem in Iran. From 44 million surgeries performed in the US in 2003, 6.8 million were related to the cardiovascular system, 467,000 were related to coronary artery bypass grafting (CABG), and 93,000 were valve-related. The annual cost of coronary artery diseases in the US is nearly $142 billion (2,3,4,9). Coronary artery bypass grafting (CABG) is a common treatment method for ischemic heart disease. This surgery is not only essential to survival, but also relieves the angina pains and helps increase the quality of life (5-9)

Full Text:

PDF


DOI: http://dx.doi.org/10.21746/ijbio.2015.02.0010

Refbacks

  • There are currently no refbacks.




Copyright (c) 2015 International Journal of Bioassays

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

International Journal of Bioassays is a member of the Publishers International Linking Association, Inc. (PILA), CROSSREF and CROSSMARK (USA). Digital Object Identifier (DOI) will be assigned to all its published content.